In a groundbreaking achievement, scientists have developed the first gene-editing medicine tailored for a baby suffering from a rare DNA condition. After successful treatments, KJ Muldoon is now healthier and ready to go home, showcasing a promising future for gene therapies.
As organ shortages persist, scientists explore xenotransplantation — transplanting animal organs into humans. Discover the groundbreaking history and future potential of this life-saving innovation.
In a groundbreaking case, a 6-month-old baby boy named KJ was treated with a personalized CRISPR gene-editing therapy, correcting a dangerous mutation before it could threaten his life. This innovative approach promises hope for similar cases.
In a historic move, the FDA has approved the first-ever blood test designed to diagnose Alzheimer's disease, marking a significant advancement in early detection and treatment options for patients.
A baby diagnosed with a rare genetic disorder has shown remarkable improvement after receiving an experimental gene editing treatment tailored just for him. This groundbreaking therapy offers hope for others with similar conditions.
KJ Muldoon, born with a deadly genetic disorder, received a groundbreaking CRISPR treatment just six months after birth. His remarkable progress showcases the future of personalized medicine for rare diseases.
In a historic first, 19-year-old Karla Flores undergoes a pioneering surgery to remove a rare spinal tumor through her eye socket. Surgeons face unprecedented challenges but aim for a life-saving outcome.
A groundbreaking urine test for prostate cancer has shown remarkable accuracy, outperforming traditional blood tests. Set to enter clinical trials, this innovation may make routine screenings a reality, potentially saving thousands of lives.
